Skip to content

Clinical trials

Phase 1 Retinitis Pigmentosa trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 1 Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20092
20111
20125
20141
20151
20171
20183
20191
20213
20221
20232
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Active, not recruiting5
Unknown status4
Not yet recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University3
QLT Inc.3
National Eye Institute (NEI)2
Suzhou UgeneX Therapeutics Co., Ltd.2
University of California, Davis2
Cedars-Sinai Medical Center1
Centocor, Inc.1
Eyecure Therapeutics Inc.1
Hadassah Medical Organization1
King Khaled Eye Specialist Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa31
Retinal Degeneration4
Leber Congenital Amaurosis3
Macular Degeneration3
Retinal Diseases3
Diabetic Retinopathy2
Eye Diseases2
Stargardt Disease2
Alcoholism1
Choroideremia1

Trials

Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.